ALS Drug Relyvrio Withdrawn After Clinical Trial Failure
Amylyx Pharmaceuticals has decided to withdraw its ALS drug, Relyvrio, from the market. ALS, also known as Lou Gehrig’s disease, is a fatal disease affecting
Serving All of Georgia - Free Consultation